AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
223.93
+3.16 (1.43%)
At close: Jan 27, 2026, 4:00 PM EST
223.75
-0.18 (-0.08%)
After-hours: Jan 27, 2026, 7:57 PM EST
AbbVie Stock Forecast
Stock Price Forecast
The 18 analysts that cover AbbVie stock have a consensus rating of "Buy" and an average price target of $239.56, which forecasts a 6.98% increase in the stock price over the next year. The lowest target is $190 and the highest is $289.
Price Target: $239.56 (+6.98%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 5 | 3 | 4 | 4 |
| Buy | 12 | 12 | 12 | 11 | 9 | 8 |
| Hold | 5 | 5 | 5 | 6 | 5 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 23 | 22 | 20 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $235 → $230 | Hold | Maintains | $235 → $230 | +2.71% | Jan 27, 2026 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 8, 2026 |
| UBS | UBS | Hold Initiates $220 → $240 | Hold | Initiates | $220 → $240 | +7.18% | Jan 7, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $261 → $269 | Buy | Maintains | $261 → $269 | +20.13% | Dec 12, 2025 |
| HSBC | HSBC | Hold → Strong Buy Upgrades $225 → $265 | Hold → Strong Buy | Upgrades | $225 → $265 | +18.34% | Dec 10, 2025 |
Financial Forecast
Revenue This Year
62.19B
from 56.33B
Increased by 10.39%
Revenue Next Year
68.23B
from 62.19B
Increased by 9.72%
EPS This Year
10.13
from 2.39
Increased by 323.80%
EPS Next Year
14.52
from 10.13
Increased by 43.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 64.7B | 71.5B | ||||
| Avg | 62.2B | 68.2B | ||||
| Low | 59.6B | 64.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 14.8% | 15.0% | ||||
| Avg | 10.4% | 9.7% | ||||
| Low | 5.8% | 3.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.49 | 15.83 | ||||
| Avg | 10.13 | 14.52 | ||||
| Low | 9.70 | 12.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 338.9% | 56.3% | ||||
| Avg | 323.8% | 43.3% | ||||
| Low | 305.9% | 28.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.